Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study

Journal of Magnetic Resonance Imaging : JMRI
David F MooreRaphael Schiffmann

Abstract

To test the hypothesis that reactive oxygen species contribute to the cerebral hyperperfusion in Fabry disease. We examined the effect of intravenous injection of ascorbate on cerebral blood flow (CBF) using magnetic resonance arterial spin tagging. Nineteen patients with Fabry disease and 15 control subjects were studied as part of a randomized double-blind placebo-controlled trial of enzyme replacement therapy (ERT). Vertebro-basilar hyperperfusion was observed in patients with Fabry disease. A decrease in systemic ascorbate levels relative to healthy controls was found in the patients. CBF decreased after ascorbate infusion in both control subjects and patients treated with ERT. The placebo group had a significantly delayed decrease in the CBF response after ascorbate infusion. Myeloperoxidase levels were elevated in Fabry patients, consistent with ongoing inflammatory processes in these patients. Increased CBF in Fabry disease may be related to increased production of reactive oxygen species, while low plasma ascorbate levels suggests a global redox imbalance. These abnormalities were improved by ERT. These observations have implications regarding oxidative processes contributing to accelerated atherosclerosis in Fabry dise...Continue Reading

References

May 25, 1967·The New England Journal of Medicine·R O BradyL Laster
Jul 1, 1996·Annals of Neurology·P Mitsias, S R Levine
Oct 1, 1996·The American Journal of Physiology·T A HinterleitnerJ D Valentich
Dec 1, 1996·Nuclear Medicine Communications·K HayashidaT Nishimura
Sep 15, 1998·IEEE Transactions on Medical Imaging·D L CollinsA C Evans
Jul 14, 2000·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·F Q YeA C McLaughlin
Sep 7, 2000·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·F Q YeA C McLaughlin
Jun 21, 2001·JAMA : the Journal of the American Medical Association·R SchiffmannR O Brady
Jul 7, 2001·The New England Journal of Medicine·C M EngUNKNOWN International Collaborative Fabry Disease Study Group
Jul 7, 2001·Stroke; a Journal of Cerebral Circulation·G AltarescuR Schiffmann
Jul 21, 2001·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·D F MooreR Schiffmann
Nov 3, 2001·Stroke; a Journal of Cerebral Circulation·H A Kontos
Nov 22, 2001·JAMA : the Journal of the American Medical Association·R ZhangS L Hazen
Feb 2, 2002·Stroke; a Journal of Cerebral Circulation·David F MooreRaphael Schiffmann
Mar 13, 2002·BMC Cardiovascular Disorders·David F MooreRaphael Schiffmann
Apr 24, 2002·Antioxidants & Redox Signaling·Steve D SwainMark T Quinn
Jun 25, 2002·BMC Neurology·David F MooreRaphael Schiffmann
Sep 4, 2003·Circulation·Stephan BaldusUNKNOWN CAPTURE Investigators
Oct 24, 2003·The New England Journal of Medicine·Marie-Luise BrennanStanley L Hazen
Feb 3, 2004·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Melissa Terpstra, Rolf Gruetter

❮ Previous
Next ❯

Citations

Feb 26, 2008·Journal of Neurology·Alessandro P BurlinaOlivier Lidove
Nov 30, 2005·Virchows Archiv : an International Journal of Pathology·Raphael SchiffmannMartha Quezado
Nov 11, 2008·Journal of Inherited Metabolic Disease·T KovarnikA Linhart
Jun 6, 2009·Journal of Inherited Metabolic Disease·J M Politei
Jun 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anouk C VedderCarla E M Hollak
Apr 18, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L-S RoG-J Lee-Chen
Oct 13, 2009·Orphanet Journal of Rare Diseases·Björn Hoffmann
May 2, 2007·Proceedings of the National Academy of Sciences of the United States of America·David F MooreEhud Goldin
Feb 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·David F MooreRaphael Schiffmann
Feb 25, 2009·Expert Opinion on Biological Therapy·Michael Beck
Nov 11, 2009·Molecular Genetics and Metabolism·S M RombachC E M Hollak
Mar 26, 2009·Pharmacology & Therapeutics·Raphael Schiffmann
Mar 17, 2007·Journal of the Neurological Sciences·David F MooreRaphael Schiffmann
May 25, 2011·Internal Medicine Journal·M Tchan, D Sillence
Jul 22, 2011·Stroke Research and Treatment·U Feldt-Rasmussen
Nov 12, 2016·PloS One·Daniel RobAleš Linhart
Feb 6, 2017·Human Molecular Genetics·Jin-Song ShenTeodoro Bottiglieri
Oct 24, 2006·Arquivos de neuro-psiquiatria·Laura B JardimRoberto Giugliani
Nov 22, 2005·Lancet·Raphael Schiffmann, Markus Ries
Jul 29, 2020·Journal of Neurology·C SimonciniMichelangelo Mancuso
Apr 12, 2006·Neurology·Dimitri M HemelsoetJan L De Bleecker
Sep 28, 2017·Oxidative Medicine and Cellular Longevity·Alena JiráskováLibor Vítek
Nov 7, 2020·Metabolic Brain Disease·Patrícia VarelaJoão Bosco Pesquero
Jun 30, 2005·Neurology·Gheona AltarescuRaphael Schiffmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.